These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 12649741)
1. Intracellular mislocalization of mutant podocin and correction by chemical chaperones. Ohashi T; Uchida K; Uchida S; Sasaki S; Nihei H Histochem Cell Biol; 2003 Mar; 119(3):257-64. PubMed ID: 12649741 [TBL] [Abstract][Full Text] [Related]
2. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Nishibori Y; Liu L; Hosoyamada M; Endou H; Kudo A; Takenaka H; Higashihara E; Bessho F; Takahashi S; Kershaw D; Ruotsalainen V; Tryggvason K; Khoshnoodi J; Yan K Kidney Int; 2004 Nov; 66(5):1755-65. PubMed ID: 15496146 [TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum-retained podocin mutants are massively degraded by the proteasome. Serrano-Perez MC; Tilley FC; Nevo F; Arrondel C; Sbissa S; Martin G; Tory K; Antignac C; Mollet G J Biol Chem; 2018 Mar; 293(11):4122-4133. PubMed ID: 29382718 [TBL] [Abstract][Full Text] [Related]
4. A small molecule chaperone rescues keratin-8 mediated trafficking of misfolded podocin to correct genetic Nephrotic Syndrome. Kuzmuk V; Pranke I; Rollason R; Butler M; Ding WY; Beesley M; Waters AM; Coward RJ; Sessions R; Tuffin J; Foster RR; Mollet G; Antignac C; Edelman A; Welsh GI; Saleem MA Kidney Int; 2024 Apr; 105(4):744-758. PubMed ID: 37995908 [TBL] [Abstract][Full Text] [Related]
5. Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. Roselli S; Moutkine I; Gribouval O; Benmerah A; Antignac C Traffic; 2004 Jan; 5(1):37-44. PubMed ID: 14675423 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Huber TB; Simons M; Hartleben B; Sernetz L; Schmidts M; Gundlach E; Saleem MA; Walz G; Benzing T Hum Mol Genet; 2003 Dec; 12(24):3397-405. PubMed ID: 14570703 [TBL] [Abstract][Full Text] [Related]
7. In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation. Zhang SY; Marlier A; Gribouval O; Gilbert T; Heidet L; Antignac C; Gubler MC Kidney Int; 2004 Sep; 66(3):945-54. PubMed ID: 15327385 [TBL] [Abstract][Full Text] [Related]
8. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. Tamarappoo BK; Verkman AS J Clin Invest; 1998 May; 101(10):2257-67. PubMed ID: 9593782 [TBL] [Abstract][Full Text] [Related]
9. Kidney Organoids Generated Using an Allelic Series of NPHS2 Point Variants Reveal Distinct Intracellular Podocin Mistrafficking. Dorison A; Ghobrial I; Graham A; Peiris T; Forbes TA; See M; Das M; Saleem MA; Quinlan C; Lawlor KT; Ramialison M; Howden SE; Little MH J Am Soc Nephrol; 2023 Jan; 34(1):88-109. PubMed ID: 36167728 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones. Cheong HI; Cho HY; Park HW; Ha IS; Choi Y Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330 [TBL] [Abstract][Full Text] [Related]
11. A disease-causing mutation illuminates the protein membrane topology of the kidney-expressed prohibitin homology (PHB) domain protein podocin. Schurek EM; Völker LA; Tax J; Lamkemeyer T; Rinschen MM; Ungrue D; Kratz JE; Sirianant L; Kunzelmann K; Chalfie M; Schermer B; Benzing T; Höhne M J Biol Chem; 2014 Apr; 289(16):11262-11271. PubMed ID: 24596097 [TBL] [Abstract][Full Text] [Related]
12. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms. Fan Q; Zhang H; Ding J; Liu S; Miao J; Xing Y; Yu Z; Guan N Genes Cells; 2009 Sep; 14(9):1079-90. PubMed ID: 19674119 [TBL] [Abstract][Full Text] [Related]
13. A missense mutation in podocin leads to early and severe renal disease in mice. Philippe A; Weber S; Esquivel EL; Houbron C; Hamard G; Ratelade J; Kriz W; Schaefer F; Gubler MC; Antignac C Kidney Int; 2008 May; 73(9):1038-47. PubMed ID: 18288100 [TBL] [Abstract][Full Text] [Related]
14. An inducible mouse model of podocin-mutation-related nephrotic syndrome. Tabatabaeifar M; Wlodkowski T; Simic I; Denc H; Mollet G; Weber S; Moyers JJ; Brühl B; Randles MJ; Lennon R; Antignac C; Schaefer F PLoS One; 2017; 12(10):e0186574. PubMed ID: 29049388 [TBL] [Abstract][Full Text] [Related]
15. Structural characterization and mutational assessment of podocin - a novel drug target to nephrotic syndrome - an in silico approach. Tabassum A; Rajeshwari T; Soni N; Raju DS; Yadav M; Nayarisseri A; Jahan P Interdiscip Sci; 2014 Mar; 6(1):32-9. PubMed ID: 24464702 [TBL] [Abstract][Full Text] [Related]
16. Mutations in NPHS2 (podocin) in Mexican children with nephrotic syndrome who respond to standard steroid treatment. Carrasco-Miranda JS; Garcia-Alvarez R; Sotelo-Mundo RR; Valenzuela O; Islas-Osuna MA; Sotelo-Cruz N Genet Mol Res; 2013 Jun; 12(2):2102-7. PubMed ID: 23913389 [TBL] [Abstract][Full Text] [Related]
18. [A novel mutation of NPHS2 identified in a Chinese family with steroid-resistant nephrotic syndrome]. Yu ZH; Ding J; Guan N; Shi Y; Zhang JJ; Huang JP; Yao Y; Yang JY Zhonghua Er Ke Za Zhi; 2004 Feb; 42(2):108-12. PubMed ID: 15059485 [TBL] [Abstract][Full Text] [Related]
19. Podocin localizes in the kidney to the slit diaphragm area. Roselli S; Gribouval O; Boute N; Sich M; Benessy F; Attié T; Gubler MC; Antignac C Am J Pathol; 2002 Jan; 160(1):131-9. PubMed ID: 11786407 [TBL] [Abstract][Full Text] [Related]
20. Protein synthesis inhibitors and the chemical chaperone TMAO reverse endoplasmic reticulum perturbation induced by overexpression of the iodide transporter pendrin. Shepshelovich J; Goldstein-Magal L; Globerson A; Yen PM; Rotman-Pikielny P; Hirschberg K J Cell Sci; 2005 Apr; 118(Pt 8):1577-86. PubMed ID: 15784681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]